These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 8268374

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. 2-Chlorodeoxyadenosine (2-CdA) in chronic lymphocytic leukemia refractory to fludarabine?
    Schirmer M, Michlmayr G, Geisen F, Konwalinka G.
    Leukemia; 1996 Jul; 10(7):1253-4. PubMed ID: 8684013
    [No Abstract] [Full Text] [Related]

  • 23. Severe autoimmune hemolytic anemia following fludarabine therapy in a patient with chronic lymphocytic leukemia.
    Tsiara S, Christou L, Konstantinidou P, Panteli A, Briasoulis E, Bourantas KL.
    Am J Hematol; 1997 Apr; 54(4):342. PubMed ID: 9092698
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Visceral varicella in a patient with chronic lymphocytic leukemia treated with fludarabine: a case report.
    Freedberg DE, Bhadelia N, Poneros JM, Oster MW.
    Clin Lymphoma Myeloma Leuk; 2013 Feb; 13(1):90-2. PubMed ID: 23103084
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. What choices are available for treatment of the patient with chronic lymphocytic leukemia who is fludarabine-refractory?
    Byrd JC, Rai KR.
    Semin Oncol; 2000 Aug; 27(4):xii-xv; discussion xv-xvi. PubMed ID: 10950363
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Delayed and long-lasting complete response to fludarabine in two patients with B-cell chronic lymphocytic leukemia.
    Zaja F, Russo D, Marin L, Silvestri F, Ramello M, Baccarani M.
    Ann Hematol; 1999 Sep; 78(9):435-6. PubMed ID: 10525833
    [No Abstract] [Full Text] [Related]

  • 33. Acute tumor lysis syndrome during oral fludarabine treatment for CLL--a rare event that might be observed more frequently in the future.
    Rioufol C, Coiffier B.
    Onkologie; 2008 Apr; 31(4):157-8. PubMed ID: 18418014
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Fever and dyspnea in a patient with chronic lymphatic leukemia under treatment with fludarabine].
    Díaz-Pedroche C, Lizasoain M, Folgueira D, Giménez-Mesa E, Aguado JM.
    Enferm Infecc Microbiol Clin; 2006 Jan; 24(1):61-3. PubMed ID: 16537066
    [No Abstract] [Full Text] [Related]

  • 36. Chronic lymphocytic leukemia in the elderly population.
    Rai KR.
    Clin Geriatr Med; 1997 May; 13(2):245-9. PubMed ID: 9115449
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Idiopathic thrombocytopenic purpura and myasthenia gravis after fludarabine treatment for chronic lymphocytic leukemia.
    Fujimaki K, Takasaki H, Koharazawa H, Takabayashi M, Yamaji S, Baba Y, Kanamori H, Ishigatsubo Y.
    Leuk Lymphoma; 2005 Jul; 46(7):1101-2. PubMed ID: 16019566
    [Abstract] [Full Text] [Related]

  • 40. Oral high-dose glucocorticoids and ofatumumab in fludarabine-resistant chronic lymphocytic leukemia.
    Spaner DE.
    Leukemia; 2012 May; 26(5):1144-5. PubMed ID: 22064354
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.